RGP Forms and Documents

Internal Form:

• The following are samples (NOT fillable forms!) of the assurance declarations you will be required to complete in the Internal Form for any such activities relevant to your research project:
  • Research involving human subjects/specimens
  • Research involving animals
  • Research involving recombinant DNA or potentially hazardous biomaterials
  • Research involving selected infectious agents and toxins - see updated list from 17/1/17 (further to new regulations of the pathogens law, approved by the Knesset) (see letter from VP and handbook below)

Assurances:

As per Weizmann Institute standard procedures, Compliance declarations are to be made in the Internal Form (see above), stating whether each of the following will be used in a research project:

• Animal Care and Use: Submission of protocols to the Institutional Animal Care and Use Committee (IACUC) (allow at least 4 weeks for processing).
• Safety and Environmental Issues: Safety Unit Approval Form (Submit to dana.gancz@weizmann.ac.il).
• Human Subjects/Specimens Research:
  • See a letter from the WIS Bioethics committee, dated 16 June 2014, regarding revised Bioethics guidelines for human cell lines
  • Download the IRB Application Form. Submit to Prof. Yosef Shaul, Department of Molecular Genetics, Head of the Weizmann Institutional Review Board (IRB), for any research involving human subjects/specimens research (including educational research involving collection of data from human subjects).
  • Download the Human Participant Protections Education for Research Teams PDF, published by the US DHHS, Nov. 2002.
  • Guidelines (May 2013) regarding research that does not constitute a "clinical trial".
  • Download Form 1 - Application for Approval of Research that does not Constitute a Clinical Trial in Human Subjects.
  • See a letter from the Vice President, dated 7 May 2013, to Weizmann Institute researchers involved in human subjects/specimens research.
  • See a letter from the Vice President, dated 24 August 2010, to Weizmann Institute researchers regarding the establishment of the Weizmann Bioethics and ESCRO Committee.
  • See a letter from the Vice President, dated 31 May 2009, to Weizmann Institute researchers involved in human subjects/specimens research.
  • See a letter from the Vice President, dated 26 May 2009, regarding the activation of projects involving human subjects/specimens research.
• Institutional Biosafety Committee (IBC):
  • Recombinant DNA and Gene Transfer: Submit the Recombinant DNA form (to Dr. Dana Gancz) for research involving recombinant DNA. Exempt experiments are listed in the table. Exemption excludes recombinant DNA from risk group 3-4. This form does not cover other biological materials/hazardous agents (see below).
  • Hazardous Biomaterials: Submit the general IBC form (to Dr. Dana Gancz) if the research requiring approval involves other biological hazardous agents or narcotic materials (excluding those used for animals anesthesia).
• Institutional Committee for Research Using Infectious Agents (ICRUIA):
  • Submit the Infectious Agents form (available in Microsoft Word format or in PDF format) (Submit to dana.gancz@weizmann.ac.il) if the research requiring approval involves selected infectious agents and toxins (updated list from 22/12/20). Note: The form includes one affidavit page in Hebrew; Macintosh users should therefore open the Word file using NeoOffice or Microsoft Word 2011, or alternatively, download the PDF file.
  • See a letter from the Vice President dated 6/5/2010 to Weizmann researchers regarding compliance with Israeli national legislation on scientific research involving infectious agents and WIS regulations for compliance with Israeli legislation on Scientific research involving infectious agents.
• NIH: The NIH requires that for every submitted NIH application, each PI submit to the RGP (to be kept on file):
  • A PI Assurance of Compliance (see http://grants.nih.gov/grants/guide/notice-files/NOT-OD-06-054.html).
  • A PI Disclosure Summary of Financial Conflict of Interest (FCOI) (see http://grants.nih.gov/grants/policy/coi/index.htm).
• U.S. DoD: The U.S. DoD announced that, as of 9 August 2024, it is prohibited from funding or making an award of a fundamental research project proposal in which a covered individual is participating in a Malign Foreign Talent Recruitment Program (MFTRP), or to a proposing institution that does not have a policy addressing MFTRP. Therefore, please be aware of and review here WIS MFTRP Policy.

External Agency Forms:

• Israel Ministry of Science (IMOS) Semi-Annual Declaration (also available in **PDF format).

Miscellaneous:

• Biographical Sketch Form (based on NIH form).
• Internal Grants - Instructions for preparing Reports.
• KAMAR (Keren Mash'abei Mechkar) - reporting guidelines and allowable expenses

**Please note: Fillable PDF forms can only be saved if you are using the full Adobe Acrobat program. For those using the free Adobe Reader, the form cannot be saved, and must therefore be filled out and printed in the same session.